Xebra Brands
Source: Xebra Brands.
  • Xebra Brands (XBRA) has announced a $600,000 private placement and a share consolidation
  • The consolidation will occur on February 28, 2023, on the basis of 1 post-consolidation share for each 5 pre-consolidation shares
  • The non-brokered financing will consist of up to 8,000,000 units priced, on a post-consolidated basis, at $0.075 each
  • Xebra Brands is an international cannabis cultivation and consumer product company
  • Xebra Brands (XBRA) opened with a gain of 25 per cent trading at $0.025 per share

Xebra Brands (XBRA) has announced a $600,000 private placement and a share consolidation.

The consolidation will occur on February 28, 2023, on the basis of 1 post-consolidation share for each 5 pre-consolidation shares. Any fraction of a common share will be rounded up or down to the nearest whole number.

As a result of the consolidation, Xebra’s outstanding common shares will be reduced to 39,339,581, on a pre-offering basis.

The non-brokered financing will consist of up to 8,000,000 units priced, on a post-consolidated basis, at $0.075 each.

Each unit is comprised of one common share and one common share purchase warrant.

Each warrant entitles the holder to acquire one common share for $0.10 for up to 18 months following the closing of the financing.

The company expects the financing to close on or about March 1, 2023.

All securities issued are subject to a hold period of four months and one day.

Xebra Brands is an international cannabis cultivation and consumer product company.

Xebra Brands (XBRA) opened with a gain of 25 per cent trading at $0.025 per share.


More From The Market Online
Canopy USA Announces Appointment of Mr. M. Brooks Jorgensen as President (CNW Group/Canopy USA)

Meet Canopy USA’s new CEO, Brooks Jorgensen

Canopy Growth (TSX:WEED) is naming Brooks Jorgensen as the first-ever president of its U.S.-based holding company, Canopy USA.
Brazil flag on cannabis background

MediPharm Labs grows into Brazilian cannabis market

MediPharm Labs (TSX:LABS) signs an agreement with Laboratório Teuto to offer two products in the Brazilian cannabis market.
Stock Talk Cannabis Report image of cannabis plants and VW van

StockTalk | Cannabis Report: Organic and inorganic growth

Delota (CSE:NIC) posted its third consecutive quarter of positive adjusted EBITDA for the quarter ended October 31, 2024.
Canadian flag, medical equipment and stock chart

The top 10 Canadian medical stocks

The Canadian medical industry powers numerous high-potential stocks whose products and services lie at the foundation of human life.